362 related articles for article (PubMed ID: 32989331)
1. Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung.
Faustino LD; Griffith JW; Rahimi RA; Nepal K; Hamilos DL; Cho JL; Medoff BD; Moon JJ; Vignali DAA; Luster AD
Nat Immunol; 2020 Nov; 21(11):1371-1383. PubMed ID: 32989331
[TBL] [Abstract][Full Text] [Related]
2. IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs.
Chen CC; Kobayashi T; Iijima K; Hsu FC; Kita H
J Allergy Clin Immunol; 2017 Nov; 140(5):1351-1363.e7. PubMed ID: 28196763
[TBL] [Abstract][Full Text] [Related]
3. The ST2
Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cell-derived IL-1Ra suppresses the innate response to respiratory viral infection.
Griffith JW; Faustino LD; Cottrell VI; Nepal K; Hariri LP; Chiu RS; Jones MC; Julé A; Gabay C; Luster AD
Nat Immunol; 2023 Dec; 24(12):2091-2107. PubMed ID: 37945820
[TBL] [Abstract][Full Text] [Related]
5. IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury.
Liu Q; Dwyer GK; Zhao Y; Li H; Mathews LR; Chakka AB; Chandran UR; Demetris JA; Alcorn JF; Robinson KM; Ortiz LA; Pitt BR; Thomson AW; Fan MH; Billiar TR; Turnquist HR
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30779711
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-33-Dependent Accumulation of Regulatory T Cells Mediates Pulmonary Epithelial Regeneration During Acute Respiratory Distress Syndrome.
Tan W; Zhang B; Liu X; Zhang C; Liu J; Miao Q
Front Immunol; 2021; 12():653803. PubMed ID: 33936076
[TBL] [Abstract][Full Text] [Related]
7. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
[TBL] [Abstract][Full Text] [Related]
8. IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells.
Matta BM; Lott JM; Mathews LR; Liu Q; Rosborough BR; Blazar BR; Turnquist HR
J Immunol; 2014 Oct; 193(8):4010-20. PubMed ID: 25217167
[TBL] [Abstract][Full Text] [Related]
9. Bcl6 and Blimp1 reciprocally regulate ST2
Koh B; Ulrich BJ; Nelson AS; Panangipalli G; Kharwadkar R; Wu W; Xie MM; Fu Y; Turner MJ; Paczesny S; Janga SC; Dent AL; Kaplan MH
J Allergy Clin Immunol; 2020 Nov; 146(5):1121-1136.e9. PubMed ID: 32179158
[TBL] [Abstract][Full Text] [Related]
10. The alarmins IL-1 and IL-33 differentially regulate the functional specialisation of Foxp3
Alvarez F; Istomine R; Shourian M; Pavey N; Al-Aubodah TA; Qureshi S; Fritz JH; Piccirillo CA
Mucosal Immunol; 2019 May; 12(3):746-760. PubMed ID: 30872761
[TBL] [Abstract][Full Text] [Related]
11. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
[TBL] [Abstract][Full Text] [Related]
12. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma.
Böhm L; Maxeiner J; Meyer-Martin H; Reuter S; Finotto S; Klein M; Schild H; Schmitt E; Bopp T; Taube C
J Immunol; 2015 Feb; 194(3):887-97. PubMed ID: 25527785
[TBL] [Abstract][Full Text] [Related]
13. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
[TBL] [Abstract][Full Text] [Related]
14. IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.
Popovic B; Golemac M; Podlech J; Zeleznjak J; Bilic-Zulle L; Lukic ML; Cicin-Sain L; Reddehase MJ; Sparwasser T; Krmpotic A; Jonjic S
PLoS Pathog; 2017 Apr; 13(4):e1006345. PubMed ID: 28448566
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
16. Brain Foxp3
Guo S; Luo Y
Int Immunopharmacol; 2020 Apr; 81():106027. PubMed ID: 31791672
[TBL] [Abstract][Full Text] [Related]
17. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
Front Immunol; 2018; 9():2004. PubMed ID: 30233590
[TBL] [Abstract][Full Text] [Related]
20. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.
Cottagiri M; Nyandjo M; Stephens M; Mantilla JJ; Saito H; Mackay IR; Rose NR; Njoku DB
Cell Mol Immunol; 2019 Aug; 16(8):706-717. PubMed ID: 30030493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
